Drug Type Small molecule drug |
Synonyms ISM5043 |
Target |
Mechanism KAT6A inhibitors(lysine acetyltransferase 6A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
ER-positive/HER2-negative Breast Cancer | Preclinical | CN | 07 Jan 2024 | |
Breast Cancer | Preclinical | US | 04 Jan 2024 |